104 related articles for article (PubMed ID: 27684197)
1. Improving the Intracellular Drug Concentration in Lung Cancer Treatment through the Codelivery of Doxorubicin and miR-519c Mediated by Porous PLGA Microparticle.
Wu D; Wang C; Yang J; Wang H; Han H; Zhang A; Yang Y; Li Q
Mol Pharm; 2016 Nov; 13(11):3925-3933. PubMed ID: 27684197
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer.
Wang C; Yang J; Han H; Chen J; Wang Y; Li Q; Wang Y
Int J Nanomedicine; 2017; 12():827-837. PubMed ID: 28182125
[TBL] [Abstract][Full Text] [Related]
3. Combination of doxorubicin-based chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles.
Shi X; Li C; Gao S; Zhang L; Han H; Zhang J; Shi W; Li Q
Colloids Surf B Biointerfaces; 2014 Oct; 122():498-504. PubMed ID: 25082753
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.
Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
Biomaterials; 2013 Sep; 34(27):6444-53. PubMed ID: 23755831
[TBL] [Abstract][Full Text] [Related]
5. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.
Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
Biomaterials; 2012 Aug; 33(22):5574-83. PubMed ID: 22579235
[TBL] [Abstract][Full Text] [Related]
7. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
8. Inhalable functional mixed-polymer microspheres to enhance doxorubicin release behavior for lung cancer treatment.
Li W; Chen S; Zhang L; Zhang Y; Yang X; Xie B; Guo J; He Y; Wang C
Colloids Surf B Biointerfaces; 2020 Dec; 196():111350. PubMed ID: 32911292
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
11. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
[TBL] [Abstract][Full Text] [Related]
12. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ
J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
Mosafer J; Teymouri M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
[TBL] [Abstract][Full Text] [Related]
14. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.
Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S
Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699
[TBL] [Abstract][Full Text] [Related]
15. An ATP-Responsive Codelivery System of Doxorubicin and MiR-34a To Synergistically Inhibit Cell Proliferation and Migration.
Wang Y; Chen J; Liang X; Han H; Wang H; Yang Y; Li Q
Mol Pharm; 2017 Jul; 14(7):2323-2332. PubMed ID: 28591517
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-triggered PLGA microparticle destruction and degradation for controlled delivery of local cytotoxicity and drug release.
Jang KW; Seol D; Ding L; Heo DN; Lee SJ; Martin JA; Kwon IK
Int J Biol Macromol; 2018 Jan; 106():1211-1217. PubMed ID: 28851638
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles.
Chittasupho C; Lirdprapamongkol K; Kewsuwan P; Sarisuta N
Eur J Pharm Biopharm; 2014 Oct; 88(2):529-38. PubMed ID: 25119723
[TBL] [Abstract][Full Text] [Related]
18. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
[TBL] [Abstract][Full Text] [Related]
19. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
